HTC
Hershey Trust Company’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-33,758
| Closed | -$1.53M | – | 6 |
|
2023
Q3 | $1.53M | Hold |
33,758
| – | – | 0.01% | 4 |
|
2023
Q2 | $1.9M | Hold |
33,758
| – | – | 0.01% | 5 |
|
2023
Q1 | $1.53M | Hold |
33,758
| – | – | 0.01% | 4 |
|
2022
Q4 | $1.37M | Hold |
33,758
| – | – | 0.01% | 5 |
|
2022
Q3 | $2.21M | Hold |
33,758
| – | – | 0.02% | 5 |
|
2022
Q2 | $2.05M | Hold |
33,758
| – | – | 0.02% | 13 |
|
2022
Q1 | $2.12M | Hold |
33,758
| – | – | 0.02% | 15 |
|
2021
Q4 | $2.56M | Hold |
33,758
| – | – | 0.02% | 15 |
|
2021
Q3 | $3.78M | Buy |
33,758
+9,234
| +38% | +$1.03M | 0.04% | 11 |
|
2021
Q2 | $3.97M | Buy |
24,524
+7,645
| +45% | +$1.24M | 0.04% | 8 |
|
2021
Q1 | $2.06M | Buy |
+16,879
| New | +$2.06M | 0.02% | 8 |
|
2020
Q4 | – | Sell |
-4,925
| Closed | -$412K | – | 33 |
|
2020
Q3 | $412K | Buy |
+4,925
| New | +$412K | ﹤0.01% | 12 |
|
2017
Q4 | – | Sell |
-42,991
| Closed | -$768K | – | 18 |
|
2017
Q3 | $768K | Buy |
+42,991
| New | +$768K | 0.01% | 9 |
|